Where we have done well …
The above are all areas in which SA has improved by varying degrees, especially PMTCT, where major reductions in HIV infections have for the first time put almost zero transmission within reach, achieving world acclaim. Vaccines for children were a growing local success story, with rates of invasive pneumococcal disease -including cases caused by antibiotic-resistant bacteriahaving fallen substantially following the introduction of a pneumococcal conjugate vaccine. The rate of infections resistant to two different antibiotics had declined nearly twice as much as that for infections that could be treated with antibiotics. This proportionately greater effect of vaccination on antibiotic-resistant strains pointed to a very valuable added benefit of immunisation. Zar said that a maternal influenza vaccine during pregnancy had also recently been shown to substantially reduce influenza in mothers and their babies, and was a strategy that should be strengthened as a matter of urgency. Despite official and scientifically backed recommendations for the influenza vaccine to be prioritised for pregnant women, uptake remained very low.
Zar described as 'very exciting' current overseas work on the development of a vaccine for respiratory syncytial virus (RSV), which causes infections of the lungs and respiratory tract. RSV is so common that most children have been infected with it by age 2. In adults and older, healthy children, the symptoms of respiratory syncytial virus are mild and typically mimic the common cold. Self-care measures are usually all that are needed to relieve any discomfort, but infection can be severe in in premature babies and infants with underlying health conditions (and in older adults, adults with heart and lung diseases, or anyone with a very weak immune system). Zar said that a major part of her enthusiasm was due to the strategy to immunise pregnant women against RSV as a way of protecting their infants.
Overall, she said, strengthening health systems, reducing poverty and improving the coverage and uptake of these known effective interventions would see SA beginning to make quicker, long-awaited progress in reducing the neonatal mortality and under-5 mortality (and morbidity) rates.
Leading by example with innovation
Zar, a past president of the South African Thoracic Society and president of the Pan African Thoracic Society, currently chairs the Forum of the International Respiratory Societies. She achieved world acclaim with her low-cost plastic cooldrink bottle spacer for asthmatic children, which rendered what used to be expensive inhalers accessible to millions of children in poorer communities. Her invention made the oral alternative therapy, theophylline (a white crystalline alkaloid and vasodilator with several unpleasant side-effects), a thing of the past. The use of cooldrink bottles as asthma spacers is now included in guidelines from the Global Initiative for Asthma and the World Health Organization (WHO). Another surprisingly simple advance that she and her Red Cross War Memorial Hospital team came up withnow also included in WHO guidelines and national recommendations -is the use of less invasive sputum induction for rapid tuberculosis (TB) testing in children. A few years ago it was widely believed that children couldn't provide enough sputum for a TB test. Instead doctors used gastric lavage or stomach pumping, a process that involved starving a child overnight, then sticking a tube down their nostrils or throat into their stomach, and sucking all the contents out. Children were subjected to this process three days in a row before doctors could retrieve a specimen large enough for testing. Zar and her team found that by nebulising a child beforehand and suctioning the back of their throat very quickly, it is possible to induce enough sputum for a rapid TB test (using
